PrymaLab Analytical
Public test results
Results that clients chose to publish, plus PrymaLab's own lot certificates of analysis, newest first. Each line links to the full report. For client samples we list the brand or source exactly as the client declared it and have no relationship with any of the companies named; a listing is not an endorsement. Lines marked Lot COA are PrymaLab production lots tested in our own laboratory.
109 published results
| Test | Compound tested | Declared as | Brand / source | Result | Verdict | Published |
|---|---|---|---|---|---|---|
| PL-26-00091 Lot COA |
Semaglutide 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-091 |
PrymaLab | 99.24% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00090 Lot COA |
Semaglutide 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-090 |
PrymaLab | 99.32% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00089 Lot COA |
Selank 11 mg In-house lot release testing |
11 mg/vial Lot PL-2609-089 |
PrymaLab | 99.45% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00088 Lot COA |
Selank 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-088 |
PrymaLab | 99.72% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00087 Lot COA |
Retatrutide 60 mg In-house lot release testing |
60 mg/vial Lot PL-2609-087 |
PrymaLab | 99.27% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00086 Lot COA |
Retatrutide 50 mg In-house lot release testing |
50 mg/vial Lot PL-2609-086 |
PrymaLab | 99.35% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00085 Lot COA |
Retatrutide 40 mg In-house lot release testing |
40 mg/vial Lot PL-2609-085 |
PrymaLab | 99.44% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00084 Lot COA |
Retatrutide 30 mg In-house lot release testing |
30 mg/vial Lot PL-2609-084 |
PrymaLab | 99.38% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00083 Lot COA |
Retatrutide 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-083 |
PrymaLab | 99.31% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00082 Lot COA |
Retatrutide 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-082 |
PrymaLab | 99.24% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00081 Lot COA |
Retatrutide 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-081 |
PrymaLab | 99.33% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00080 Lot COA |
PT-141 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-080 |
PrymaLab | 99.42% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00079 Lot COA |
Prostamax 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-079 |
PrymaLab | 99.56% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00078 Lot COA |
PNC-27 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-078 |
PrymaLab | 99.57% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00077 Lot COA |
PNC-27 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-077 |
PrymaLab | 99.62% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00073 Lot COA |
PEG-MGF (Mechano Growth Factor) 2 mg In-house lot release testing |
2 mg/vial Lot PL-2609-073 |
PrymaLab | 99.76% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00072 Lot COA |
Pancragen 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-072 |
PrymaLab | 99.54% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00071 Lot COA |
P21 (P021) 5 mg In-house lot release testing |
5 mg/vial Lot PL-2609-071 |
PrymaLab | 99.52% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00069 Lot COA |
Ovagen 20 mg In-house lot release testing |
20 mg/vial Lot PL-2609-069 |
PrymaLab | 99.52% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00068 Lot COA |
NAD+ 1,000 mg In-house lot release testing |
1000 mg/vial Lot PL-2609-068 |
PrymaLab | 99.81% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00067 Lot COA |
NAD+ 500 mg In-house lot release testing |
500 mg/vial Lot PL-2609-067 |
PrymaLab | 99.88% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00066 Lot COA |
MT-2 (Melanotan II acetate) 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-066 |
PrymaLab | 99.81% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00065 Lot COA |
MT-1 (Melanotan I) 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-065 |
PrymaLab | 99.62% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00064 Lot COA |
MOTS-c 40 mg In-house lot release testing |
40 mg/vial Lot PL-2609-064 |
PrymaLab | 99.56% purity | Released: PASS | Oct 3, 2026 |
| PL-26-00063 Lot COA |
MOTS-c 10 mg In-house lot release testing |
10 mg/vial Lot PL-2609-063 |
PrymaLab | 99.61% purity | Released: PASS | Oct 3, 2026 |
A verdict compares what we measured with what the label claimed: within 10% is "matches label". Client reports describe the sample received and say nothing about where it came from. "Released: PASS" on a lot COA means the PrymaLab lot met every specification on its certificate. Want your own result here? Order a test and tick "publish".
